Form 4 for WST West Pharmaceutical Services
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001127602-23-028965 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-05 | 2023-12-01 | WST | Winters Chad | VP, CAO | S - Sale+OE | $349.00 | -1,013 | 1,270 | -44% | -$353.5K |
| DM | 2023-12-05 | 2023-12-01 | WST | Winters Chad | VP, CAO | M - OptEx | $156.18 | +797 | 1,942 | +70% | +$124.5K |
| DM | 2023-12-05 | 2023-12-01 | WST | Winters Chad | VP, CAO | M - OptEx | $0.00 | -797 | 1,571 | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | S | D | 1,013 | $349.00 | 1,269.70 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-01 | M | A | 341 | $173.22 | 2,282.70 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-01 | M | A | 456 | $143.43 | 1,941.70 | D | — | — | |
| 4 | Derivative | Stock Options (Right to Buy) | 2023-12-01 | M | D | 456 | $0.00 | 0 | D | $143.43 · 2020-10-29 to 2029-10-29 | 456 Stock Options (Right to Buy) | |
| 5 | Derivative | Stock Options (Right to Buy) | 2023-12-01 | M | D | 341 | $0.00 | 1,571 | D | $173.22 · 2021-02-18 to 2030-02-18 | 341 Stock Options (Right to Buy) |